Tilray Brands, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Irwin David Simon
- Full Time Employees
- 3,595
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 265 Talbot Street West Leamington ON Canada N8H 5L4
- IPO Date
- Jul 19, 2018
- CIK
- 0001731348
- Website
- tilray.com
- Similar Companies
- Business
- Tilray Brands, Inc. (TLRY) is a global lifestyle consumer products company that researches, cultivates, processes, and distributes medical and adult-use cannabis products; alcoholic and non-alcoholic beverages including craft beers from brands such as Blue Point Brewing Company, Breckenridge Brewery, Green Flash Brewing Company, Redhook Ale Brewery, Shock Top, SweetWater Brewing Company, Widmer Brothers Brewery, Montauk Brewing Company, Alpine Beer Company, and Terrapin Beer Company; hemp-based foods and drinks; energy drinks like HiBall Energy; and wellness products encompassing CBD-infused edibles and other non-combustible cannabis formats. Founded in 2013 and headquartered in New York City with principal operations in Canada including facilities in Nanaimo, British Columbia, the company maintains a global footprint spanning Australia, New Zealand, Latin America including recent approvals in Panama, growing cultivation in Germany and Portugal, and distribution in Europe such as Poland and Italy, alongside U.S. beverage exposure. Tilray serves medical cannabis patients, adult recreational users, and consumer packaged goods markets including craft beer enthusiasts and wellness consumers across its four primary segments of cannabis, beverages, wellness, and distribution. In recent developments, Tilray completed Craft Acquisition II effective September 1, 2024, integrating four additional craft brands and breweries to bolster its beverage portfolio; advanced Project 420 for operational synergies targeting $25 million in cost savings through supply chain optimization, brand investments, and efficiency measures; expanded international medical cannabis access with key regulatory approvals and product launches in Panama, Germany, Italy, and Australia; and launched new products including Delta-9 THC-derived beverages and energy drinks while enhancing distribution networks, particularly in global markets. The company, formed through the 2020 reverse merger with Aphria and subsequent 2023 acquisitions of eight Anheuser-Busch beverage brands for $85 million, continues to diversify beyond cannabis into beverages and wellness amid evolving regulations and market growth. Tilray ranks as the ninth-largest craft beer producer in the U.S. by volume and reports ongoing gross profit increases, with Q2 2025 results showing 29% year-over-year growth to $61 million across all segments.
Company News
West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers
Tilray Brands (TSE:TLRY) Sets New 52-Week Low – Here’s Why
Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?
SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia
Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets
BrewDog Acquisition Boosts Tilray's Q1 Performance
Tilray Q1: Not Looking Good, Remains A 'Hold'
3 Huge Red Flags From Tilray's Q1 Earnings Report
Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?
3 Reasons I'm Still Not Buying Tilray Stock -- Even at Penny-Stock Prices
Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
Tilray Brands, Inc. (TLRY) Q1 2027 Earnings Call Transcript
Tilray Brands Q1 Earnings Call Highlights
Tilray revenue rises as beverage business drives record quarterly sales
Tilray Brands Not Dependent on Single Market, CEO Highlights Multiple Growth Engines
Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease
Tilray Brands, Inc. (TLRY) Reports Q1 Loss, Misses Revenue Estimates
Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution
Tilray Brands stock analysis ahead of earnings: will it rebound or fall further?
BrewDog's Winning Streak Rolls on with Gold at the Scottish Beer Awards